Latest Insider Transactions at Zentalis Pharmaceuticals, Inc. (ZNTL)
This section provides a real-time view of insider transactions for Zentalis Pharmaceuticals, Inc. (ZNTL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Zentalis Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Zentalis Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
            Nov 23                          
            2020                          
           | Kevin D. Bunker Chief Scientific Officer | 
              SELL
             
                Open market or private sale
             | Indirect | 
              8,425
              -2.85%
           | 
              $387,550              
              $46.85 P/Share              
           | 
| 
            Nov 23                          
            2020                          
           | Kevin D. Bunker Chief Scientific Officer | 
              BUY
             
                Bona fide gift
             | Indirect | 
              101,045
              +50.0%
           | 
              -                 
           | 
| 
            Nov 23                          
            2020                          
           | Kevin D. Bunker Chief Scientific Officer | 
              SELL
             
                Bona fide gift
             | Direct | 
              101,045
              -8.58%
           | 
              -                 
           | 
| 
            Nov 23                          
            2020                          
           | Epperly Melissa B, Chief Financial Officer | 
              SELL
             
                Open market or private sale
             | Direct | 
              3,083
              -0.52%
           | 
              $141,818              
              $46.88 P/Share              
           | 
| 
            Nov 22                          
            2020                          
           | Anthony Y Sun President & CEO | 
              BUY
             
                Bona fide gift
             | Indirect | 
              213,600
              +50.0%
           | 
              -                 
           | 
| 
            Nov 22                          
            2020                          
           | Anthony Y Sun President & CEO | 
              SELL
             
                Bona fide gift
             | Direct | 
              213,600
              -10.59%
           | 
              -                 
           | 
| 
            Oct 28                          
            2020                          
           | Recurium Equity, LLC > 10% Shareholder | 
              SELL
             
                Other acquisition or disposition
             | Direct | 
              4,147,940
              -99.64%
           | 
              -                 
           | 
| 
            Apr 07                          
            2020                          
           | David Michael Johnson Director | 
              BUY
             
                Open market or private purchase
             | Direct | 
              4,000
              +3.37%
           | 
              $72,000              
              $18.0 P/Share              
           | 
| 
            Apr 07                          
            2020                          
           | Anthony Y Sun President & CEO | 
              BUY
             
                Open market or private purchase
             | Direct | 
              888
              +0.04%
           | 
              $15,984              
              $18.0 P/Share              
           | 
| 
            Apr 07                          
            2020                          
           | Kevin D. Bunker Chief Scientific Officer | 
              BUY
             
                Open market or private purchase
             | Direct | 
              350
              +0.03%
           | 
              $6,300              
              $18.0 P/Share              
           | 
| 
            Apr 07                          
            2020                          
           | Epperly Melissa B, Chief Financial Officer | 
              BUY
             
                Open market or private purchase
             | Direct | 
              20,000
              +6.3%
           | 
              $360,000              
              $18.0 P/Share              
           | 
| 
            Apr 07                          
            2020                          
           | Viking Global Investors LP > 10% Shareholder | 
              BUY
             
                Open market or private purchase
             | Indirect | 
              725,000
              +14.03%
           | 
              $13,050,000              
              $18.0 P/Share              
           |